6. Funahashi Y, et al. Eribulin mesylate triggers vasculature remodeling to reduce the abnormality of tumor microenvironment of human breast cancer models. Submitted. 2014.
7. World Health Organisation. Atlas of Health in Europe. 2003. World Health Organization, Regional Office of Europe, Copenhagen, Denmark.
8. Wendt MK, Tian M, Schiemann WP. Deconstructing the mechanisms and consequences of TGF-beta-induced EMT during cancer progression. Cell and Tissue Res 2012;347:85-101
9. Principe D, et al. TGF-beta: duality of function between tumor prevention and carcinogenesis. Journal of the National Cancer Institute 2014:106:djt369.
CONTACT: Media Enquiries: Eisai, Cressida Robson / Ben Speller, +44(0)7908 314 155 / +44(0) 7908 409416, Cressida_Robson@eisai.net,Ben_Speller@eisai.net / Tonic Life Communications, Alex Davies / CallumHaire, +44 (0) 7716 324722 / +44 (0) 7867 429637, Alex.Davies@toniclc.com,Callum.Haire@toniclc.com
Andalucía
Aragón
Cantabria
Castilla-La Mancha
Castilla y León
Catalunya
Extremadura
Galicia
Islas Canarias
Islas Baleares
Madrid
País Vasco
La Rioja
C. Valenciana
Navarra
Asturias
Murcia
Ceuta y Melilla
